MedTrace Logo

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

NCT05819827 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2025-04-27

No results posted yet for this study

Summary

The objective of this pilot cohort study is to investigate associations between CIN and changes in gut microbiome composition profiles.

Conditions

Interventions

OTHER

Blood and Tissue

Patients will collect stool for microbiome analysis at baseline (i.e., 3 +2 days prior to chemotherapy) and again 5-7 days following initiation of chemotherapy. Blood samples will be collected prior to their first chemotherapy treatment, and in the second week after chemotherapy.

Sponsors & Collaborators

Principal Investigators

  • Komal P. Singh, Ph.D., R.N. · Mayo Clinic

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-19
Primary Completion
2024-05-21
Completion
2024-05-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819827 on ClinicalTrials.gov